Search results
Results from the WOW.Com Content Network
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB. The medical standard for active TB is a short course treatment involving a combination of isoniazid , rifampicin (also known as Rifampin), pyrazinamide , and ethambutol for the first two months.
Directly observed treatment, short-course (DOTS, also known as TB-DOTS) is the name given to the tuberculosis (TB) control strategy recommended by the World Health Organization. [1] According to WHO, "The most cost-effective way to stop the spread of TB in communities with a high incidence is by curing it.
During the American colonial era, tuberculosis was a major health concern in the Philippines. In 1910, a regional meeting was held in Manila and it was reported the mortality of the disease is estimated to be 40,000. [4] The health situation led to the establishment of the Philippine Islands Anti-Tuberculosis Society on July 29, 1910.
Medication costs can be the selling price from the manufacturer, that price together with shipping, the wholesale price, the retail price, and the dispensed price. [3]The dispensed price or prescription cost is defined as a cost which the patient has to pay to get medicines or treatments which are written as directions on prescription by a prescribers. [4]
Treatment success rates were lower than 50% in Ukraine, Mozambique, Indonesia and India. Areas with poor TB surveillance infrastructure had higher rates of loss to follow-up of treatment. [68] Before the discovery of effective antibiotics in the early 1940s, a collapsed lung might be triggered deliberately as a treatment for tuberculosis.
As of September 2020, the Philippines has a population of nearly 110 million and a population density of 368 per square kilometer. 32% of the population of the Philippines is under 15 years old, and only 22.2% is over 60. In the Philippines, 16.6% of the population lived below the national poverty line in 2018. [8] [9]
The Global Fund’s investments have reduced deaths from HIV, tuberculosis, and malaria by 61% since 2002, saving 65 million lives. [25] Recent efforts include lowering the cost of key treatments for drug-resistant TB by 55% and first-line HIV medications by 25%, while introducing a more effective insecticide-treated mosquito net. [26]
Roughly one-quarter of the world's population has been infected with M. tuberculosis, [6] with new infections occurring in about 1% of the population each year. [11] However, most infections with M. tuberculosis do not cause disease, [169] and 90–95% of infections remain asymptomatic. [87] In 2012, an estimated 8.6 million chronic cases were ...